Source:http://linkedlifedata.com/resource/pubmed/id/18029973
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-28
|
pubmed:abstractText |
Although disease-free survival (DFS) is accepted as a valid end point in adjuvant breast cancer trials, improvement in 2-year DFS has never been formally established as an adequate correlate for 5-year overall survival (OS). We set out to ascertain if changes in 2-year DFS can be used to accurately predict 5-year OS changes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1569-8041
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-6
|
pubmed:meshHeading |
pubmed-meshheading:18029973-Breast Neoplasms,
pubmed-meshheading:18029973-Disease-Free Survival,
pubmed-meshheading:18029973-Female,
pubmed-meshheading:18029973-Humans,
pubmed-meshheading:18029973-Lymphatic Metastasis,
pubmed-meshheading:18029973-Neoplasm Recurrence, Local,
pubmed-meshheading:18029973-Neoplasms, Second Primary,
pubmed-meshheading:18029973-Survival Rate
|
pubmed:year |
2008
|
pubmed:articleTitle |
Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006.
|
pubmed:affiliation |
Department of Medical Oncology and Hematology, Princess Margaret Hospital, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|